0001437749-22-019667.txt : 20220809 0001437749-22-019667.hdr.sgml : 20220809 20220809190047 ACCESSION NUMBER: 0001437749-22-019667 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220807 FILED AS OF DATE: 20220809 DATE AS OF CHANGE: 20220809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelderman Kim CENTRAL INDEX KEY: 0001739054 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 221149920 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 rdgdoc.xml FORM 4 X0306 4 2022-08-07 0000842023 BIO-TECHNE Corp TECH 0001739054 Kelderman Kim 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 1 Pres. Diagnostics & Genom Common Stock 2022-08-07 4 M 0 2363 0 A 4352 D Common Stock 2022-08-07 4 F 0 1214 382.97 D 3138 D Stock Option (Right to Buy) 150.7800 2025-05-01 Common Stock 7511 7511 D Stock Option (Right to Buy) 177.3200 2025-08-08 Common Stock 12044 12044 D Stock Option (Right to Buy) 177.3200 2025-08-08 Common Stock 9033 9033 D Restricted Stock Units 2022-08-07 4 M 0 2363 0 D Common Stock 2363 0 D Stock Option (Right to Buy) 190.4100 2026-08-07 Common Stock 11961 11961 D Stock Option (Right to Buy) 190.4100 2026-08-07 Common Stock 15948 15948 D Restricted Stock Units Common Stock 2015 2015 D Stock Option (Right to Buy) 267.8700 2027-08-05 Common Stock 8991 8991 D Stock Option (Right to Buy) 267.8700 2027-08-05 Common Stock 11988 11988 D Stock Option (Right to Buy) 267.8700 2027-08-05 Common Stock 8325 8325 D Stock Option (Right to Buy) 267.8700 2027-08-05 Common Stock 8325 8325 D Restricted Stock Units Common Stock 1245 1245 D Stock Option (Right to Buy) 481.8200 2028-08-06 Common stock 6486 6486 D Stock Option (Right to Buy) 481.8200 2028-08-06 Common Stock 4864 4864 D Fully exercisable. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/7/2022, the Board of Directors certified vesting of 2,363 performance RSUs. Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024. Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025. /s/ Brenda S. Furlow as Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed. 2022-08-09